跳至主要内容
临床试验/CTRI/2023/05/052432
CTRI/2023/05/052432招募中3 期

A study to assess the effect of virechana karma as compared to the standard treatment in the management of non-alcoholic fatty liver disease in relation to yakritodara.

Ayurvedic and Unani Tibbia college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients diagnosed with case of NAFLD grade- I/II/III by USG.

排除标准

  • 1) Patients who are contraindicated for virechana karma- like lower GI bleeding, Prolapse of rectum, incontinence of stool, pregnant and lactating mothers etc. will not be included in the trial group.
  • 2) Patients taking antifungal, antibacterial, or antibiotic medication.
  • 3) Patients with Ascites, Liver cirrhosis, Oesophageal varices, Jaundice, Cholelithiasis.
  • 4) Patients with history of Cholecystectomy.
  • 5) Patients requiring emergency treatment.

研究者

发起方
Ayurvedic and Unani Tibbia college and hospital

相似试验